Lexaria Bioscience LEXX
NASDAQ LEXX
$2.88 -0.21 (-6.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Property, Plant & Equipment (Net) (2011 - 2026)

Updated

Lexaria Bioscience (LEXX) posted Property, Plant & Equipment (Net) of $229,017 for fiscal Q3 2026 (quarter ended May 31, 2026), down 4.6% from $240,139 a year earlier and down 5.7% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Property, Plant & Equipment (Net) came in at $228,129, down 10.4% from FY2024.

  • Annual Property, Plant & Equipment (Net) shows a five-year compound annual growth rate of -13.9% (FY2020 to FY2025).
  • In prior fiscal years, Lexaria Bioscience's Property, Plant & Equipment (Net) was $254,709 in FY2024 (+0.2%), $254,143 in FY2023 (-19.4%), $315,505 in FY2022 (-14.3%) and $368,213 in FY2021 (-23.8%).
  • Quarterly Property, Plant & Equipment (Net) has run from a low of $216,120 in fiscal Q1 2026 to a high of $368,213 in fiscal Q4 2021 over five years.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined in each of the last four quarters, with an average decline of 0.1% over the last eight quarters.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was fiscal Q1 2025, with growth of 15.8%; the weakest was fiscal Q1 2024, with a decline of 24.9%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior fiscal quarters was $242,931 (Q2 2026), $216,120 (Q1 2026) and $228,129 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Lexaria Bioscience 3.04 Mn -12.61 Mn - 229,017.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 229,017.00
Feb 28, 2026 242,931.00
Nov 30, 2025 216,120.00
Aug 31, 2025 228,129.00
May 31, 2025 240,139.00
Feb 28, 2025 261,890.00
Nov 30, 2024 270,621.00
Aug 31, 2024 254,709.00
May 31, 2024 219,289.00
Feb 29, 2024 226,315.00
Nov 30, 2023 233,639.00
Aug 31, 2023 254,143.00
May 31, 2023 276,898.00
Feb 28, 2023 301,421.00
Nov 30, 2022 311,221.00
Aug 31, 2022 315,505.00
May 31, 2022 343,431.00
Aug 31, 2021 368,213.00
Feb 28, 2021 423,205.00
Nov 30, 2020 452,355.00
API Access

Lexaria Bioscience Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=LEXX&period=max&api_key=YOUR_API_KEY